Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer.

Attia, Steven; Eickhoff, Jens; Wilding, George; McNeel, Douglas; Blank, Jules; Ahuja, Harish; Jumonville, Alcee; Eastman, Michael; Shevrin, Daniel; Glode, Michael; Alberti, Dona; Staab, Mary Jane; Horvath, Dottie; Straus, Jane; Marnocha, Rebecca; Liu, Glenn

Attia, Steven; Eickhoff, Jens; Wilding, George; McNeel, Douglas; Blank, Jules; Ahuja, Harish; Jumonville, Alcee; Eastman, Michael; Shevrin, Daniel; Glode, Michael; Alberti, Dona; Staab, Mary Jane; Horvath, Dottie; Straus, Jane; Marnocha, Rebecca; Liu, Glenn.

Affiliation

Attia S; University of Wisconsin Paul P. Carbone Comprehensive Cancer Center, Madison, WI 53792, USA.

Clin Cancer Res ; 14(8): 2437-43, 2008 Apr 15.

Article in En | MEDLINE | ID: mdl-18413835

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Ergocalciferols/administration & dosage; Prostatic Neoplasms/drug therapy; Taxoids/therapeutic use; Aged; Aged, 80 and over; Androgens/physiology; Calcium/blood; Calcium/urine; Docetaxel; Double-Blind Method; Ergocalciferols/adverse effects; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms/mortality; Taxoids/administration & dosage; Taxoids/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Ergocalciferols / Taxoids Type of study: Clinical_trials Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2008 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google